MEDI:CC News and Press, WELLBEING DIGITAL SCIENCES INC. From 11/14/22

MEDI:CC - Wellbeing Subsidiary KGK Science Announces Successful Delivery of CBD and THC Through the Skin of Healthy Volunteers

Gefion Canada GT4 technology was used to deliver cannabidiol (CBD) and tetrahydrocannabinol (THC) to healthy volunteers in the form of a topical cream applied to the skin Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (N...

MEDI:CC - Wellbeing Digital Subsidiary KGK to Participate in Microdose Wonderland Miami Conference

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including...

MEDI:CC - Wellbeing Announces Definitive Agreement to Divest IRP Health

PURSUANT TO COMPLETION OF DUE DILIGENCE, WELLBEING WILL DIVEST ITS EQUITY STAKE IN IRP Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcar...

MEDI:CC - Wellbeing Digital to Participate at this Years' Wonderland Miami Conference

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including...

MEDI:CC - Wellbeing Digital Subsidiary KGK to Participate in the Supply Side West Conference

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including...

MEDI:CC - Wellbeing Digital and Subsidiary KGK Science Applauds the Government of Alberta's Move to Regulate the Use of Psychedelics

Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including...

MEDI:CC - Wellbeing Subsidiary KGK Science Announces Psilocybin Microdose Capsule Formulation to be Submitted to Health Canada for Phase 2A Trial

The psilocybin 1.5mg capsules are available for potential therapeutic use in non-ASD clinical trials, including but not limited to diabetes, heart disease, cancer, and post-traumatic stress disorder Wellbeing Digital Sciences Inc. (“ Wellbeing” or the ...

MEDI:CC - Wellbeing Digital Signs LOI Manage Additional Clinics

With the Company’s extensive experience in this sector, we are eager to replicate the growth and profitability success of our clinics at additional sites within our clinical ecosystem Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ C...

MEDI:CC - Wellbeing Digital to Participate in the Cantor Fitzgerald Symposium on Mental Health Clinics

Wellbeing Digital Sciences Inc. (“ Wellbeing ” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, includin...

MEDI:CC - Wellbeing Subsidiary KGK Science Opens New Clinical Research Center to Reimagine a Healthier Future

New Clinical Facility in London, Ontario Accelerates Research and Innovation Wellbeing Digital Sciences Inc. (“ Wellbeing” or the “ Company ”) (NEO: MEDI ) (OTC: KONEF ) (FRA: SQ2 ), an evidence-based mental healthcare company ...

Company Name:	WELLBEING DIGITAL SCIENCES INC.
Stock Symbol:	MEDI:CC
Market:	AQNC
Website:	wellbeingdigital.co